Yoshimi Anzai M.D., M.P.H.

Yoshimi Anzai M.D., M.P.H.

Bio

Dr. Anzai's educational and professional experience has spanned four universities in the United States and Japan. She is a member of multiple national and…

Read Full Bio

Patient Care Philosophy

I think it is vitally important for radiologists to interact with patients. While radiologists are often invisible to patients, I would like to spend as much as time possible answering patient questions regarding their diagnostic tests in order to improve efficiency of care and patient satisfaction.

Clinical Interests

Head and neck cancer, neurodegenerative disease, traumatic brain injury, impact of diagnostic test on clinical outcomes, cost effectiveness research

Research Interests

Physiologic cancer imaging, Dementia, Parkinson disease, Concussion.

Education

InstitutionCredentialYear
Univ. of Washington, School of Public Health & Community MedicineMaster Public Health2005
Chiba University School of MedicineMedical education1986
UCLA-Dept. of Radiological SciencesFellowship
UCLA-Dept. of Radiological SciencesFellowship
Univ. of Michigan - Dept. of RadiologyResidency
Univ. of Michigan-NeuroradiologyFellowship

DegreeDescriptionYear
MD1986

Board Certifications

CertificationSpecialtyYear
American Board of RadiologyNeuroradiology2002
American Board of RadiologyDiagnostic Radiology1988
Dr. Anzai's educational and professional experience has spanned four universities in the United States and Japan. She is a member of multiple national and international professional societies. She is also the Vice President of the American Society of Head and Neck Radiology, the Secretary of AUR board of Directors, the president-elect of the American Association for Women Radiologists, and Co-Director of Women in Medicine at the University of Washington. She also serves as a member of the ACR Appropriateness Criteria Methodology Committee.

She is involved with various research studies, including ACRIN 6685 for head and neck cancer with N0 neck, evaluation of brain iron deposition in Parkinson disease patients, metabolic and vascular uncoupling of advanced head and neck cancer, and imaging assessment of cochlear implants.